Skip to content

Interest Expense at other companies

Insmed logo
InsmedINSM
$20.08M-6.9%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$4.2M
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$9K-52.6%
uniQure logo
uniQureQURE
$14.03M-7.1%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$1.21M
Biogen logo
BiogenBIIB

Other financials

Income statement

See full
Revenue$2.0M-40.6%
Operating income-$57.3M-43.1%
Net income-$56.7M-44.4%
EPS (diluted)-$0.52+11.9%

Balance sheet

See full
Cash & equivalents$297.1M+41.1%
Total debt$20.7M-12.5%
Total equity$374.1M+27.1%
Total assets$422.9M+23.0%

Cash flow

See full
Operating cash flow-$47.2M-48.3%
CapEx$165.0K+31.0%
Free cash flow-$47.4M-48.2%

Valuation

See full
Market cap$872.26M+135%
Enterprise value$595.83M+223%
P/S107.8×-9.9×

Profitability

See full
Operating margin-1,315.2%-4,060pp
Net margin-1,062.3%-251,151pp
FCF margin-1,247.7%-9,569pp

Returns & leverage

See full
Return on equity-57.4%+2.2pp
Debt / equity0.1×0.0×
Current ratio13.1×+2.2×

Where this comes from

Reported directly by Solid Biosciences Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Solid Biosciences Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solid Biosciences Inc.'s interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Solid Biosciences Inc.'s interest expense?
Solid Biosciences Inc. (SLDB) reported interest expense of $0 in Q4 2025.
How has Solid Biosciences Inc.'s interest expense changed year-over-year?
Solid Biosciences Inc.'s interest expense decreased by 100.0% year-over-year, from $75K to $0.
What is the long-term trend for Solid Biosciences Inc.'s interest expense?
Over 2 years (2023 to 2025), Solid Biosciences Inc.'s interest expense has grown at a -31.2% compound annual growth rate (CAGR), from $439K to -$208K.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.